Print Mode Enable Media Only

News chronological

2 items before 1150971 (Keyword: "david-sinclair" (~2 currently found))

MEGAPHONE (Joe Rogan) - #2537 - David Sinclair

David Sinclair, AO, PhD, is a longevity scientist, Professor of Genetics at Harvard Medical School, author of the book "Lifespan: Why We Age—and Why We Don't Have To," and host of the "Lifespan" podcast.www.youtube.com/c/davidsinclairpodcast  www.simonandschuster.com/books/Lifespan/David-Sinclair/9781501191978  https://lifespan.com  https://davidasinclair.com Perplexity: Download the app or ask Perplexity anything at https://pplx.ai/rogan. Visit https://superpower.com/rogan for $20 off your membership. This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE Learn more about your ad choices. Visit podcastchoices.com/adchoices

David Sinclair, AO, PhD, is a longevity scientist, Professor of Genetics at Harvard Medical School, author of the book "Lifespan: Why We Age—and Why We Don't Have To," and host of the "Lifespan" podcast. www.youtube.com/c/davidsinclairpodcast    www.simonandschuster.com/books/Lifespan/David-Sinclair/9781501191978    https://lifespan.com    https://davidasinclair.com Perplexity: Download the app or ask Perplexity anything at https://pplx.ai/rogan . Visit https://superpower.com/rogan for $20 off your membership. This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE Learn more about your ad choices. Visit podcastchoices.com/adchoicesOpen

Channelt.me/News_Wire
Sourcehttps://traffic.megaphone.fm/GLT1521681560.mp3
Keywordsdavid-sinclairjoe-roganlongevitygeneticsharvard-medical-schoollifespananti-aginghealthsciencebiologyhuman-healthdnapodcastingjrewellnessbiohackingagingmedical-researchacademiclife-extensionlifestylenutritionstem-cellsgene-expressionbiology-research

AXIOS (Caitlin Owens) - Longevity medicine's do-or-die moment

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one of the longevity field's most promising theories. Why it matters: The early-stage clinical trial will signal whether "cellular reprogramming" can be performed safely in humans, a prerequisite for any future claim that a treatment can slow or even reverse biological aging. The big picture: Attempts to prolong the human lifespan can refer to anything from better diet and exercise to the infusion of blood plasma from young donors. - The former is validated by decades of science; the latter has merited two warnings from the Food and Drug Administration that said such treatments lack any evidence of clinical benefit. …

Channelt.me/News_Wire2
Sourcehttps://www.axios.com/2026/06/18/longevity-medicine-critical-moment
Keywordslongevitymedicinecellular-reprogramminggene-therapybiotechhealthagingclinical-trialsfdalife-biosciencesdavid-sinclairnewlimitbrian-armstrongretro-biosciencessam-altmanaltos-labsjeff-bezosbiological-agingsciencemedical-researchepigeneticglaucomabiopharmatech-billionaireslife-expectancywellness